Literature DB >> 21239529

In vivo function of airway epithelial TLR2 in host defense against bacterial infection.

Qun Wu1, Di Jiang, Maisha N Minor, Richard J Martin, Hong Wei Chu.   

Abstract

Decreased Toll-like receptor 2 (TLR2) expression has been reported in patients with chronic obstructive pulmonary disease and in a murine asthma model, which may predispose the hosts to bacterial infections, leading to disease exacerbations. Since airway epithelial cells serve as the first line of respiratory mucosal defense, the present study aimed to reveal the role of airway epithelial TLR2 signaling to lung bacterial [i.e., Mycoplasma pneumoniae (Mp)] clearance. In vivo TLR2 gene transfer via intranasal inoculation of adenoviral vector was performed to reconstitute TLR2 expression in airway epithelium of TLR2(-/-) BALB/c mice, with or without ensuing Mp infection. TLR2 and lactotransferrin (LTF) expression in airway epithelial cells and lung Mp load were assessed. Adenovirus-mediated TLR2 gene transfer to airway epithelial cells of TLR2(-/-) mice reconstituted 30-40% TLR2 expression compared with TLR2(+/+) cells. Such airway epithelial TLR2 reconstitution in TLR2(-/-) mice significantly reduced lung Mp load (an appropriate 45% reduction), coupled with elevated LTF expression. LTF expression in mice was shown to be mainly dependent on TLR2 signaling in response to Mp infection. Exogenous human LTF protein dose-dependently decreased lung bacterial load in Mp-infected TLR2(-/-) mice. In addition, human LTF protein directly dose-dependently decreased Mp levels in vitro. These data indicate that reconstitution of airway epithelial TLR2 signaling in TLR2(-/-) mice significantly restores lung defense against bacteria (e.g., Mp) via increased lung antimicrobial protein LTF production. Our findings may offer a deliverable approach to attenuate bacterial infections in airways of asthma or chronic obstructive pulmonary disease patients with impaired TLR2 function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239529      PMCID: PMC3075102          DOI: 10.1152/ajplung.00336.2010

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  40 in total

Review 1.  Multifunctional roles of lactoferrin: a critical overview.

Authors:  P P Ward; E Paz; O M Conneely
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

2.  Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.

Authors:  L A Håversen; I Engberg; L Baltzer; G Dolphin; L A Hanson; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas.

Authors:  W E Finkbeiner; S D Carrier; C E Teresi
Journal:  Am J Respir Cell Mol Biol       Date:  1993-11       Impact factor: 6.914

4.  Enhanced protection against fatal mycobacterial infection in SCID beige mice by reshaping innate immunity with IFN-gamma transgene.

Authors:  Z Xing; A Zganiacz; J Wang; S K Sharma
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

Review 5.  Relationships among the composition of mucus, epithelial lining liquid, and adhesion of microorganisms.

Authors:  J Widdicombe
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

6.  Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma.

Authors:  M Kraft; G H Cassell; J E Henson; H Watson; J Williamson; B P Marmion; C A Gaydos; R J Martin
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

7.  Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection.

Authors:  Jaclyn R Stonebraker; Danielle Wagner; Robert W Lefensty; Kimberlie Burns; Sandra J Gendler; Jeffrey M Bergelson; Richard C Boucher; Wanda K O'Neal; Raymond J Pickles
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation.

Authors:  X F Lei; Y Ohkawara; M R Stämpfli; J Gauldie; K Croitoru; M Jordana; Z Xing
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease.

Authors:  B M W Diederen; P D L P M van der Valk; J A W J Kluytmans; M F Peeters; R Hendrix
Journal:  Eur Respir J       Date:  2007-04-25       Impact factor: 16.671

10.  Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Mandira Varma-Basil; Shailendra K D Dwivedi; Krishna Kumar; Rakesh Pathak; Ritika Rastogi; S S Thukral; Malini Shariff; V K Vijayan; Sunil K Chhabra; Rama Chaudhary
Journal:  J Med Microbiol       Date:  2009-03       Impact factor: 2.472

View more
  14 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M.

Authors:  Qun Wu; Di Jiang; Sean Smith; Jyoti Thaikoottathil; Richard J Martin; Russell P Bowler; Hong Wei Chu
Journal:  J Allergy Clin Immunol       Date:  2011-12-09       Impact factor: 10.793

3.  A novel mouse model of conditional IRAK-M deficiency in myeloid cells: application in lung Pseudomonas aeruginosa infection.

Authors:  Di Jiang; Jennifer Matsuda; Reena Berman; Niccolette Schaefer; Connor Stevenson; James Gross; Bicheng Zhang; Amelia Sanchez; Liwu Li; Hong Wei Chu
Journal:  Innate Immun       Date:  2016-12-18       Impact factor: 2.680

4.  Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague.

Authors:  Rachel M Olson; Miqdad O Dhariwala; William J Mitchell; Jerod A Skyberg; Deborah M Anderson
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

5.  Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation.

Authors:  Niccolette Schaunaman; Amelia Sanchez; Kris Genelyn Dimasuay; Nicole Pavelka; Mari Numata; Rafeul Alam; Richard J Martin; Hong Wei Chu
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

6.  Toll-like receptor-2/6 and Toll-like receptor-9 agonists suppress viral replication but not airway hyperreactivity in guinea pigs.

Authors:  Matthew G Drake; Scott E Evans; Burton F Dickey; Allison D Fryer; David B Jacoby
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

7.  Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.

Authors:  Matthew Faron; Joshua R Fletcher; Jed A Rasmussen; Michael A Apicella; Bradley D Jones
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

8.  Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis.

Authors:  Santanu Banerjee; Jana Ninkovic; Jingjing Meng; Umakant Sharma; Jing Ma; Richard Charboneau; Sabita Roy
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

9.  Airway epithelial NF-κB activation promotes Mycoplasma pneumoniae clearance in mice.

Authors:  Di Jiang; Mark L Nelson; Fabienne Gally; Sean Smith; Qun Wu; Maisha Minor; Stephanie Case; Jyoti Thaikoottathil; Hong Wei Chu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications.

Authors:  Natalija Van Braeckel-Budimir; Bert Jan Haijema; Kees Leenhouts
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.